SCYNEXIS, Inc. to Present at Canaccord Genuity Growth Conference 2014
August 06, 2014 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that Yves J. Ribeill, Ph.D., SCYNEXIS' President and...
SCYNEXIS, Inc. to Present at JMP Securities Healthcare Conference
June 18, 2014 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., June 18, 2014 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that Yves J. Ribeill, Ph.D., SCYNEXIS' President and...
SCYNEXIS Provides Update on Corporate Progress and First Quarter 2014 Financial Results
June 16, 2014 08:30 ET
|
SCYNEXIS, Inc.
RESEARCH TRIANGLE PARK, N.C., June 16, 2014 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX), a clinical-stage company focused on developing novel anti-infectives to address drug-resistant infections,...